2005
DOI: 10.1242/jcs.02435
|View full text |Cite
|
Sign up to set email alerts
|

A unique lysophospholipid acyltransferase (LPAT) antagonist, CI-976, affects secretory and endocytic membrane trafficking pathways

Abstract: Previous studies have shown that inhibition of a Golgi-complex-associated lysophospholipid acyltransferase (LPAT) activity by the drug CI-976 stimulates Golgi tubule formation and subsequent redistribution of resident Golgi proteins to the endoplasmic reticulum (ER). Here, we show that CI-976 stimulates tubule formation from all subcompartments of the Golgi complex, and often these tubules formed independently, i.e. individual tubules usually did not contain markers from different subcompartments. Whereas the … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
20
0

Year Published

2006
2006
2014
2014

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 32 publications
(23 citation statements)
references
References 45 publications
3
20
0
Order By: Relevance
“…However, recent results question the importance of the acyltransferase activity of endophilin and CtBP/BARS in the formation of transport vesicles (Gallop et al, 2005). Alternatively, it is very interesting that the compound CI-976, a potent lysophospholipid acyltransferase inhibitor, has been reported to block transport of both the transferrin receptor from the ERC to the plasma membrane as well as Golgi transport (Chambers et al, 2005). Other models are also consistent with our results.…”
Section: Discussionsupporting
confidence: 89%
“…However, recent results question the importance of the acyltransferase activity of endophilin and CtBP/BARS in the formation of transport vesicles (Gallop et al, 2005). Alternatively, it is very interesting that the compound CI-976, a potent lysophospholipid acyltransferase inhibitor, has been reported to block transport of both the transferrin receptor from the ERC to the plasma membrane as well as Golgi transport (Chambers et al, 2005). Other models are also consistent with our results.…”
Section: Discussionsupporting
confidence: 89%
“…Our previous studies have revealed a novel role for LPATs, and specifically AGPAT3/LPAAT3, in regulating the structure and function of the Golgi complex [7,22,23]. AGPAT3/LPAAT3 appears to negatively regulate the formation of Golgi membrane tubules that likely serve as trafficking intermediates for plasma membrane delivery and for maintenance of an intact Golgi ribbon.…”
Section: Resultsmentioning
confidence: 99%
“…6A). CI-976, a small, hydrophobic, membrane-permeant compound which inhibits COP II vesicle budding from the ER (Chambers and Brown, 2004; Chambers et al, 2005), reduced cell viability by more than 50% relative to control cells ( p <0.0001), while CytoD, a fungal metabolite that inhibits actin polymerization in the cell cytoskeleton (Ramm et al, 1994), reduced viability by 25% ( p <0.0006; Fig. 6B).…”
Section: Resultsmentioning
confidence: 99%